Solid Biosciences (SLDB) Receivables - Other (2020 - 2022)
Solid Biosciences (SLDB) has disclosed Receivables - Other for 3 consecutive years, with $14000.0 as the latest value for Q1 2022.
- Quarterly Receivables - Other fell 95.0% to $14000.0 in Q1 2022 from the year-ago period, while the trailing twelve-month figure was $14000.0 through Mar 2022, down 95.0% year-over-year, with the annual reading at $110000.0 for FY2021, N/A changed from the prior year.
- Receivables - Other hit $14000.0 in Q1 2022 for Solid Biosciences, down from $110000.0 in the prior quarter.
- In the past five years, Receivables - Other ranged from a high of $594000.0 in Q3 2021 to a low of $14000.0 in Q1 2022.
- Historically, Receivables - Other has averaged $261666.7 across 3 years, with a median of $283000.0 in 2020.
- Biggest five-year swings in Receivables - Other: changed 0.0% in 2021 and later plummeted 95.0% in 2022.
- Year by year, Receivables - Other stood at $286000.0 in 2020, then plummeted by 61.54% to $110000.0 in 2021, then tumbled by 87.27% to $14000.0 in 2022.
- Business Quant data shows Receivables - Other for SLDB at $14000.0 in Q1 2022, $110000.0 in Q4 2021, and $594000.0 in Q3 2021.